Condition
Corneal Neovascularization clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Corneal Neovascularization clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 2/3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Intrastromal anti-VEGF injection for corneal neovascularization
We will test whether injecting anti-VEGF medicine into the cornea helps adults with corneal neovascularization caused by herpes simplex keratitis.
-
Treatment of corneal neovascularization using riboflavin photo-activation
This study is testing if a light treatment with riboflavin can help people with corneal neovascularization feel better and improve their eye health.
Quick answers
How many Corneal Neovascularization clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.